Turnstone Biologics Corp (TSBX)

Turnstone Biologics Corp Azioni (TSBX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-03-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	19.31
Operating Expenses	15.88% 20.69	17.86	18.93	19.70
Operating Income/Loss	15.88% -20.69	-17.86	-18.93	-0.394
Nonoperating Income/Loss	13.13% 1.078	1.241	1.578	0.38
Income/Loss From Continuing Operations Before Tax	18.04% -19.61	-16.61	-17.35	0.068
Income Tax Expense/Benefit	109.70% 0.016	-0.165	-0.033	-0.082
Income/Loss From Continuing Operations After Tax	19.33% -19.63	-16.45	-17.32	0.068
Net Income/Loss	19.33% -19.63	-16.45	-17.32	0.068
Preferred Stock Dividends And Other Adjustments	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-
Basic Average Shares	500.48% 23.01	3.8322	17.40	-12.51
Diluted Average Shares	500.48% 23.01	3.8322	17.40	-12.51
Basic Earnings Per Share	454.17% -0.85	0.24	-1.00	3.54
Diluted Earnings Per Share	454.17% -0.85	0.24	-1.00	3.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-